HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS
Clinical trials for HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS explained in plain language.
Never miss a new study
Get alerted when new HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS trials appear
Sign up with your email to follow new studies for HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for dialysis patients: drug trial targets dangerous phosphorus levels
Disease control Recruiting nowThis study tests an experimental drug called TS-172 in 100 adults on hemodialysis who have high phosphorus levels (hyperphosphatemia). Participants will take TS-172 or a placebo alongside their current phosphate binder medication. The goal is to see if TS-172 helps more patients …
Matched conditions: HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS
Phase: PHASE3 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 26, 2026 19:36 UTC
-
New drug aims to help dialysis patients manage dangerous mineral levels
Disease control Recruiting nowThis study is testing the long-term safety and effectiveness of an investigational drug called TS-172. It is for adults on kidney dialysis who have high levels of phosphate in their blood, a common and serious problem. The goal is to see if TS-172 can safely help control these ph…
Matched conditions: HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS
Phase: PHASE3 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 20, 2026 16:14 UTC